FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.
This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.
AstraZeneca plc (LON:AZN) has amended its collaboration agreement with Ironwood Pharmaceuticals, Inc. (Ironwood) in China mainland, China Hong Kong and China Macau for Linzess* (linaclotide), a first-in-class new treatment for..
The proposed dates(1) for the 2020 Interim Dividend of BHP Group Limited and BHP Group PLC (LON:BHP) are set out below. BHP’s Dividend Reinvestment Plan (DRP) will operate in respect..
Further to Barratt Developments PLC (LON:BDEV) announcement of its annual results on 4 September 2019, copies of the Company’s Annual Report and Accounts for the financial year ended 30 June..
Direct Line Insurance Group plc (LON: DLG) announced today that Tim Harris will join the Company as Chief Financial Officer and the Board as an Executive Director on 1st October..
SSE PLC (LON:SSE) have today entered into an agreement to sell its SSE Energy Services business to OVO Energy Limited, a wholly owned subsidiary of OVO Group Limited, at an..
British American Tobacco PLC (LON:BATS) today announced an important step in a programme to simplify its business and create a more efficient, agile and focused BAT. This will ensure the..
WM Morrison Supermarkets (LON: MRW) has today provided interim results for the half year to 4th August 2019. Financial summary · Group like-for-like (LFL) sales(1) ex-fuel/ex-VAT up 0.2% (2018/19: 4.9%)..
The Life Sciences Division (TLSD), a specialist investment bank to global life sciences companies, today announced an update report on ImmuPharma plc, a pharmaceutical development company listed on AIM of..
Associated British Foods plc (LON:ABF) today issued the following update prior to entering the close period for its full year results for the 52 weeks to 14 September 2019, which..
Lloyds Banking Group plc (LON: LLOY) has today provided an update on charges relating to the mis-selling of Payment Protection Insurance (‘PPI’). At our half year results on 31 July..
Berkeley Group Holdings PLC (LON:BKG) is holding its Annual General Meeting today, at which it will provide the following Trading Update which covers the period from 1 May 2019 to..
Hiscox Ltd (LON:HSX), today announced the appointment of Joanne Musselle as its new Group Chief Underwriting Officer, after concluding a thorough internal and external search. Joanne is currently Chief Underwriting..
Melrose Industries PLC (LON:MRO) today announced its interim results for the six months ended 30 June 2019. Highlights Adjusted1 results Statutory results Continuing operations 2019 2018 2019 2018 £m..
Barratt Developments Plc (LON:BDEV) today announced its annual results for the year ended 30 June 2019. £m unless otherwise stated1,2,3 Year ended 30 June 2019 Year ended 30 June 2018..
Royal Bank of Scotland Group plc (LON:RBS) today provided an update in respect of charges related to Payment Protection Insurance (“PPI”). RBS has been implementing the FCA’s policy statement for..
AstraZeneca plc (LON:AZN) today announced that it has received marketing authorisation from China’s National Medical Products Administration for Tagrisso as a 1st-line treatment for adults with locally-advanced or metastatic non-small..
Proposed demerger of Wolseley UK The Board of Ferguson plc (LON: FERG) today announced its intention to demerge its UK operations subject to shareholder approval. The decision marks the conclusion..
DS Smith Plc (LON: SMDS), today issued a trading update in respect of the period since 1 May 2019. DS Smith will hold its Annual General Meeting at 12 noon..
Tesco Personal Finance Plc. / Tesco Bank (LON: TSCO) today confirmed the sale of its mortgage portfolio to Lloyds Banking Group (LON: LLOY) for a cash consideration of c. £3.8bn...
Brilinta reduced the risk of cardiovascular events in patients with coronary artery disease and type-2 diabetes in Phase III THEMIS trial. Additionally, Brilinta showed a more favourable clinical benefit in..
